5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT

Levin, C.L.; Koren, A.K.; Peretz, S.S.P.; Livshits, L.L.; Makhro, A.M.; Bogdanova, A.B.; Gassmann, M.G.

HemaSphere 7(S1):p 41-42, April 2023. | DOI: 10.1097/01.HS9.0000928448.56489.9

Researcher